Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Connie Chen

Showing results (131-140 of 214) with videos related to

Pageof 22
Sort By:
NPJ Breast Cancer|October 11, 2022
Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2- metastatic breast cancerHope S Rugo, Adam Brufsky, Xianchen Liu, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Real-World Treatment Patterns and Clinical Effectiveness of Palbociclib Plus an Aromatase Inhibitor as First-Line Therapy in Advanced/Metastatic Breast Cancer: Analysis from the US Syapse Learning Health NetworkJeanna Wallenta Law, Debanjali Mitra, Henry G Kaplan, et al.
Journal of Tissue Engineering|September 25, 2025
A patient-specific engineered tissue model of BAG3-mediated cardiomyopathyMargaretha A J Morsink, Bryan Z Wang, Josephine M Watkins, et al.
International Journal of Rheumatic Diseases|March 23, 2019
Efficacy and safety of tofacitinib for the treatment of rheumatoid arthritis in patients from the Asia-Pacific region: Post-hoc analyses of pooled clinical study dataEun Bong Lee, Hisashi Yamanaka, Yi Liu, et al.
Investigative Ophthalmology & Visual Science|May 7, 2010
Population density and refractive error among Chinese childrenMingzhi Zhang, Liping Li, Lizhen Chen, et al.
Future Oncology (London, England)|March 9, 2023
Prolonging the life of people with metastatic breast cancer in routine clinical practice by adding palbociclib to an aromatase inhibitor from a real-world database analysis: a plain language summaryHope S Rugo, Adam Brufsky, Xianchen Liu, et al.
Breast Cancer Research and Treatment|January 28, 2021
Characterization of chemotherapy-induced peripheral neuropathy using patient-reported outcomes and quantitative sensory testingW Iris Zhi, Raymond E Baser, Alice Kwon, et al.
Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association|December 18, 2024
Validation and repeatability assessment of the Chinese version of the Ocular Surface Disease Index (OSDI), 5-item dry eye (DEQ-5), and contact lens dry eye questionnaire-8 (CLDEQ-8) questionnairesBiyue Guo, K Y Chan, Peter H Li, et al.
American Health & Drug Benefits|June 19, 2018
Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona RegistryDimitrios A Pappas, Robert A Gerber, Heather J Litman, et al.
Targeted Oncology|July 10, 2023
Real-World Tumor Response of Palbociclib in Combination With an Aromatase Inhibitor as First-Line Therapy in Pre/Perimenopausal Women With Metastatic Breast CancerAngela DeMichele, Nicholas Robert, Connie Chen, et al.
Pageof 22

Showing results (131-140 of 214) with videos related to

Sort By:
Pageof 22
NPJ Breast Cancer|October 11, 2022
Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2- metastatic breast cancerHope S Rugo, Adam Brufsky, Xianchen Liu, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Real-World Treatment Patterns and Clinical Effectiveness of Palbociclib Plus an Aromatase Inhibitor as First-Line Therapy in Advanced/Metastatic Breast Cancer: Analysis from the US Syapse Learning Health NetworkJeanna Wallenta Law, Debanjali Mitra, Henry G Kaplan, et al.
Journal of Tissue Engineering|September 25, 2025
A patient-specific engineered tissue model of BAG3-mediated cardiomyopathyMargaretha A J Morsink, Bryan Z Wang, Josephine M Watkins, et al.
International Journal of Rheumatic Diseases|March 23, 2019
Efficacy and safety of tofacitinib for the treatment of rheumatoid arthritis in patients from the Asia-Pacific region: Post-hoc analyses of pooled clinical study dataEun Bong Lee, Hisashi Yamanaka, Yi Liu, et al.
Investigative Ophthalmology & Visual Science|May 7, 2010
Population density and refractive error among Chinese childrenMingzhi Zhang, Liping Li, Lizhen Chen, et al.
Future Oncology (London, England)|March 9, 2023
Prolonging the life of people with metastatic breast cancer in routine clinical practice by adding palbociclib to an aromatase inhibitor from a real-world database analysis: a plain language summaryHope S Rugo, Adam Brufsky, Xianchen Liu, et al.
Breast Cancer Research and Treatment|January 28, 2021
Characterization of chemotherapy-induced peripheral neuropathy using patient-reported outcomes and quantitative sensory testingW Iris Zhi, Raymond E Baser, Alice Kwon, et al.
Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association|December 18, 2024
Validation and repeatability assessment of the Chinese version of the Ocular Surface Disease Index (OSDI), 5-item dry eye (DEQ-5), and contact lens dry eye questionnaire-8 (CLDEQ-8) questionnairesBiyue Guo, K Y Chan, Peter H Li, et al.
American Health & Drug Benefits|June 19, 2018
Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona RegistryDimitrios A Pappas, Robert A Gerber, Heather J Litman, et al.
Targeted Oncology|July 10, 2023
Real-World Tumor Response of Palbociclib in Combination With an Aromatase Inhibitor as First-Line Therapy in Pre/Perimenopausal Women With Metastatic Breast CancerAngela DeMichele, Nicholas Robert, Connie Chen, et al.
Pageof 22